|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||



* Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX 77555-1031
Biomolecular Resource Facility, University of Texas Medical Branch, Galveston, TX 77555-1031
** Department of Human Biological Chemistry, University of Texas Medical Branch, Galveston, TX 77555-1031
Department of Clinical Chemistry, Karolinska Institute, Huddinge Hospital, S-141 88, Huddinge, Sweden
1 To whom correspondence should be addressed. e-mail: irpikule{at}utmb.edu
Cytochrome P450 27A1 (P450 27A1) is an important metabolic enzyme involved in bile acid biosynthesis and the activation of vitamin D3 in mammals. Recombinant P450 27A1 heterologously expressed in Escherichia coli was found to be copurified with phospholipids (PLs). The PL content varied in different preparations and was dependent on the purification protocol. A link between the increased amounts of PLs and deterioration of the enzyme substrate binding properties was also observed. Tandem negative ionization mass spectrometry identified phosphatidylglycerol (PG) as the major PL copurified with P450 27A1. Subsequent reconstitution of P450 into exogenous PG vesicles assessed the effect of this contamination on substrate binding and enzyme activity. Two other PLs, phosphatidylethanolamine (PE) and phosphatidylserine (PS), were also tested. PG and PE increased the Kd for 5ß-cholestane-3
,7
,12
-triol and cholesterol binding, whereas PS had no effect on either substrate binding. PG and PE did not significantly alter 5ß-cholestane-3
,7
,12
-triol hydroxylase activity and even stimulated cholesterol hydroxylase activity. PS inhibited 5ß-cholestane-3
,7
,12
-triol hydrolyase activity and had no effect on cholesterol hydroxylase activity.
Our study shows the potential for PLs to regulate the activity of P450 27A1 in vivo and alter the amount of cholesterol degraded through the "classical" and "alternative" bile acid biosynthetic pathways.
Abbreviations: CAD, collisionally activated dissociation; P450 27A1, cytochrome P450 27A1; ES-MS/MS, electrospray ionization tandem mass spectrometry; MW, molecular weight; PBS, potassium phosphate buffer; PE, phosphatidylethanolamine; PL, phospholipid; PG, phosphatidylglycerol; PS, phosphatidylserine; WT, wild type
Supplementary key words cytochrome P450 27A1 heterologous expression Escherichia coli bile acid biosynthesis
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
I. A. Pikuleva CHOLESTEROL-METABOLIZING CYTOCHROMES P450 Drug Metab. Dispos., April 1, 2006; 34(4): 513 - 520. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Wang, C. Zhang, A. Marimuthu, H. I. Krupka, M. Tabrizizad, R. Shelloe, U. Mehra, K. Eng, H. Nguyen, C. Settachatgul, et al. The crystal structures of human steroidogenic factor-1 and liver receptor homologue-1 PNAS, May 24, 2005; 102(21): 7505 - 7510. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |